Sanofi US News

- Everyone 6 months of age and older recommended for yearly vaccination

Recent survey findings indicate majority of adults fear spreading the flu to family and friends, yet only a third of adults 18 through 64 years of age get a flu shot

- New Prescription Lotion Offers Effective Treatment Option -

-- Breakthrough device design talks patients and caregivers through the injection process --

Technology can provide increased accuracy, efficiency for medical practices

- Four local non-profits receive donations totaling more than $185,000 -

Novel Ideas Sought on How to Better Engage Patients in Their Health

Research collaboration to explore novel target shown in pre-clinical studies to play significant role in type 1 diabetes

- Early shipments of flu vaccine allow health care providers to begin immunization and clinic plans with confidence in vaccine supply -

- Research collaboration with affiliate of Harvard Medical School aims to develop novel therapeutic approaches -

Nearly three-quarters of parents ask caregivers to use approved car safety seats and wash/sanitize their hands, yet fewer than one-fifth ask them to get an adult pertussis vaccine

- No increased risk of cancer found with Lantus® in new European and U.S. observational studies -

- Lixisenatide with basal insulin helped type 2 diabetes patients with uncontrolled HbA1c achieve target blood glucose levels -

- First FDA Cleared Blood Glucose Meter that Connects Directly to iPhone® and iPod touch® -

- Pediatric Data Supplements Prior Phase II and Phase III Studies in Adults -

Birmingham Program to Improve Diabetes Management through Behavioral Economics

- Fox Foundation to sponsor a clinical trial to study Sanofi compound -

- Sanofi to commercialize LeGoo® a highly innovative FDA approved and CE marked gel that provides temporary blood vessel occlusion during surgery -

Fewer Than One in Three Survey Participants Discussed DVT/PE with Healthcare Professional

Dale and Frances Hughes Cancer Center to Receive $500,000 Donation

Challenge Now Accepting Submissions From Health Innovators and Entrepreneurs

Net Sales and Business EPS(1) up 9.2%(2) in Q4

-- Product to be commercialized by Sanofi Pasteur U.S. - an established leader in pediatric healthcare --

-- Product to be commercialized by Sanofi Pasteur U.S. - an established leader in pediatric healthcare --

- NBA Star Carlos Boozer, WNBA All-Star Tamika Catchings, NBA Legend Bob Lanier and New Jersey Nets Head Coach Avery Johnson to Serve as Campaign Ambassadors -

JOINTLY RELEASED BY SANOFI AND THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

- Ruling Provides for Restricted U.S. Launch Prior to April Trial Date -

Innovative technology to enhance level of patient care, improve office efficiencies

- Highest recognition for a commitment to the renewal of US-European relations -

ImmYounity(SM) campaign unveiled as new resource for health-care professionals and consumers

Local Demonstration Program to Implement Community-Based Diabetes Management Announced

Sanofi Collaborates with Leading Health Organizations to Help Men Take More Proactive Stance in Managing Their Disease

- Performance driven by growth platforms, Genzyme acquisition and cost savings -

Elderly patients receiving the high-dose flu vaccine had a more robust immune response to vaccination with antibody levels similar to those typical in younger adults

Addition of fourth strain to influenza vaccine intended to address potential for a mismatch between strains selected for vaccine and circulating influenza viruses

- Findings from Two-Year Pivotal Phase III TEMSO Trial Published today in The New England Journal of Medicine -

Nationwide Recipe Contest Elevates Awareness for Proper Diabetes Management

New online community for managed care leaders

AFib Educator 2.0" Includes New Animations, Resources to Improve Patient-Physician Dialogue

Sanofi demonstrates commitment to wellness and prevention starts with its own employees

U.S. Senator Robert P. Casey, Jr. and Msgr. Joseph G. Quinn Co-Chair Record Breaking Event

Fluzone® Intradermal (Influenza Virus Vaccine) offers adults new immunization option for 2011-2012 influenza season

Fluzone® Intradermal (Influenza Virus Vaccine) offers adults new immunization option for 2011-2012 influenza season